Efficacy and Cardiovascular Safety of Roxadustat in Dialysis-Dependent Chronic Kidney Disease: Pooled Analysis of Four Phase 3 Studies

INTRODUCTION: This integrated phase 3 analysis examined efficacy and cardiovascular safety for roxadustat vs erythropoiesis-stimulating agents (ESAs) in dialysis-dependent patients. METHODS: Efficacy and safety results from four phase 3, randomized, open-label studies comparing roxadustat to ESAs (P...

Descripción completa

Detalles Bibliográficos
Autores principales: Barratt, Jonathan, Sulowicz, Wladyslaw, Schömig, Michael, Esposito, Ciro, Reusch, Michael, Young, James, Csiky, Botond
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478753/
https://www.ncbi.nlm.nih.gov/pubmed/34523074
http://dx.doi.org/10.1007/s12325-021-01903-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478753/
https://www.ncbi.nlm.nih.gov/pubmed/34523074
http://dx.doi.org/10.1007/s12325-021-01903-7

Ejemplares similares